These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 7317098

  • 1. Antagonism by L-dopa of the elevation of hypothalamic epinephrine by monoamine oxidase inhibition in rats.
    Fuller RW, Hemrick-Luecke SK.
    Biochem Pharmacol; 1981 Nov 01; 30(21):3023-4. PubMed ID: 7317098
    [No Abstract] [Full Text] [Related]

  • 2. Effects of L-dopa on epinephrine concentration in rat brain: possible role of inhibition of norepinephrine N-methyltransferase by S-adenosylhomocysteine.
    Fuller RW, Hemrick-Luecke SK, Perry KW.
    J Pharmacol Exp Ther; 1982 Oct 01; 223(1):84-9. PubMed ID: 7120131
    [Abstract] [Full Text] [Related]

  • 3. Tropolone antagonism of the L-dopa-induced elevation of S-adenosylhomocysteine: S-adenosylmethionine ratio but not depletion of adrenaline in rat hypothalamus.
    Fuller RW, Perry KW, Hemrick-Leucke SK.
    J Pharm Pharmacol; 1984 Jun 01; 36(6):419-20. PubMed ID: 6146682
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Selective inhibition of monoamine oxidase type B by MDL 72145 increases the central effects of L-dopa without modifying its cardiovascular effects.
    Fozard JR, Palfreyman MG, Robin M, Zreika M.
    Br J Pharmacol; 1986 Jan 01; 87(1):257-64. PubMed ID: 3082400
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of monoamine oxidase by 3,4-dihydroxyphenyl 1-alanine and its analogs.
    DeFeudis FV.
    Rev Clin Basic Pharm; 1988 Jan 01; 7(1-4):207-8. PubMed ID: 3247497
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Elevation of epinephrine concentration in rat brain by LY51641, a selective inhibitor of type A monoamine oxidase.
    Fuller RW, Hemrick-Luecke SK.
    Res Commun Chem Pathol Pharmacol; 1981 May 01; 32(2):207-21. PubMed ID: 7244360
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of monoamine oxidase A and B and of catechol-O-methyltransferase inhibition on L-DOPA-induced circling behavior.
    Heeringa MJ, d'Agostini F, DeBoer P, DaPrada M, Damsma G.
    J Neural Transm (Vienna); 1997 May 01; 104(6-7):593-603. PubMed ID: 9444560
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cerebral metabolism of glucose in adrenalectomized rats: effect of treatment with L-DOPA and a monoamine oxidase inhibitor.
    Tyce GM, Owen CA.
    Brain Res; 1978 Dec 15; 158(2):466-9. PubMed ID: 709377
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.